With precision medicine an accepted paradigm in cancer treatment, finding the right targeted drug treatment for each patient can prove challenging. MIT chemical engineers have designed an implantable device, which is about the size [...]
The 5th issue of the GIST Cancer Journal, official journal of the LRG and the first academic journal devoted solely to GIST is now available
The side effects of traditional chemotherapy treatments are often apparent, with images of bald patients with pain-etched faces captured in photographs. For targeted therapies such as those for GIST patients and other cancers that [...]
George Demetri, MD, Senior Vice President for Experimental Therapeutics at Dana-Farber Cancer Institute, discusses the lasting benefit of targeted therapy that included Gleevec in advanced GIST at the recent 50th Annual Meeting of the American Society [...]
Here is a presentation from Life Fest 2012 by Michael Heinrich, M.D. titled GIST: From Pathology Puzzle to Targeted Therapy.